Trends in net survival for patients with stomach cancer in Japan, 2000–14 (CONCORD-3)
Japanese Journal of Clinical Oncology · 2026
DOI: 10.1093/jjco/hyaf130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, 2026. Verfasst von Masashi Matsuzaka und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics, Hirosaki University Hospital, 53, Honcho Hirosaki, Aomori, 036-8563, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Japanese Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Background
We estimated net survival trends for patients with stomach cancer registered in 16 regional population-based cancer registries in Japan that participated in the CONCORD-3 study.
Methods
We included data on adults (15–99 years) diagnosed with stomach cancer between 2000 and 2014 and followed-up for their vital status until 31 December 2014. We grouped cancer patients into three anatomic groups (proximal, distal, and overlapping regions and stomach cancer, not otherwise specified) with the International Classification of Disease for Oncology, Third edition topography codes. We estimated 5-year net survival with the Pohar Perme estimator for three calendar periods (2000–2004, 2005–2009, 2010–2014), by age group (15–44, 45–54, 55–64, 65–74, and 75–99 years), anatomic group, and stage at diagnosis. All-ages survival estimates were age-standardized using the International Cancer Survival Standard weights.
Results
Five-year net survival improved over time, from 50.5% in 2000–2004 to 57.6% and 60.3% in 2005–2009 and 2010–2014, respectively. Survival for patients with proximal stomach cancer improved from 49.7% in 2000–2004 to 53.5% 2005–2009 and plateaued to 53.1% in 2010–2014. Survival for distal stomach cancer increased from 64.8% in 2000–2004 to 67.6% and 68.2% in 2005–2009 and 2010–2014, respectively. In 2010–2014, 5-year net survival for patients with localized disease (94.8%) was much higher than survival for regional (53.7%) and distant (6.4%) disease.
Conclusions
Five-year net survival for stomach cancer improved noticeably during 2000–2014. This improvement might be due to advances in systemic chemotherapy. Although survival in distal stomach cancer had improved, no such improvement was seen in proximal stomach cancer. Standardizing esophagogastric junction cancer treatment may improve its outcomes and contribute to better survival in proximal stomach cancer overall. Scientific evaluation of screening programs is also needed to enhance the efficacy of stomach cancer control initiatives in Japan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Informatics, Hirosaki University Hospital, 53, Honcho Hirosaki, Aomori, 036-8563, Japan.
- Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom.
- Department of Epidemiology, Radiation Effects Research Foundation, 5-2 Hijiyama Park, Minami-ku, Hiroshima, 732-0815, Japan.
- Department of Health Sciences, Saitama Prefectural University, 820, Sannomiya, Koshigaya-shi, Saitama, 343-8540, Japan.
- Yamagata Prefectural Central Hospital, 180 Oaza-Aoyanagi, Yamagata, Yamagata, 990-2214, Japan.
- Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Osaka, 541-8567, Japan.
ORCID-Profile: Masashi Matsuzaka, Veronica Di Carlo, Hiromi Sugiyama, Izumi Oki, Kayo Nakata, Marisa Nishio, Isao Oze, Kaname Watanabe, Rina Tanaka, Laureline Gatellier, Isao Yoshida, Hidemi Ito, Norihiro Teramoto, Hiroto Narimatsu, Tomohiro Matsuda, Claudia Allemani
Förderung
- Japanese Ministry of Health, Labour and Welfare
Zitieren
APA
Matsuzaka, M., Di Carlo, V., Matz, M., Sugiyama, H., Oki, I., Shibata, A., Nakata, K., Saito, M. K., Nishio, M., Oze, I., Watanabe, K., Tanaka, R., Gatellier, L., Yoshida, I., Ito, H., Teramoto, N., Yamashita, N., Kaizaki, Y., Moki, F., …, & Allemani, C. (2026). Trends in net survival for patients with stomach cancer in Japan, 2000–14 (CONCORD-3). Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf130
Vancouver
Matsuzaka M, Di Carlo V, Matz M, Sugiyama H, Oki I, Shibata A, et al. Trends in net survival for patients with stomach cancer in Japan, 2000–14 (CONCORD-3). Japanese Journal of Clinical Oncology. 2026. doi:10.1093/jjco/hyaf130
BibTeX
@article{Matsuzaka2026,
author = {Matsuzaka, Masashi and Di Carlo, Veronica and Matz, Melissa and Sugiyama, Hiromi and Oki, Izumi and Shibata, Akiko and Nakata, Kayo and Saito, Mari Kajiwara and Nishio, Marisa and Oze, Isao and Watanabe, Kaname and Tanaka, Rina and Gatellier, Laureline and Yoshida, Isao and Ito, Hidemi and Teramoto, Norihiro and Yamashita, Natsumi and Kaizaki, Yasuharu and Moki, Fumitaka and Kurosawa, Katsuki and Nemoto, Yuji and Narimatsu, Hiroto and Kanemura, Seiki and Miyashiro, Isao and Mori, Daisuke and Fujita, Shin and Matsuda, Tomohiro and Coleman, Michel P and Allemani, Claudia},
title = {Trends in net survival for patients with stomach cancer in Japan, 2000–14 (CONCORD-3)},
journal = {Japanese Journal of Clinical Oncology},
year = {2026},
doi = {10.1093/jjco/hyaf130}
}
EUVIMED